Literature DB >> 12890351

[Detection of YMDD motif mutations in lamivudine-untreated patients with chronic hepatitis B].

Ming-he Yan1, Chang Zhang, Qiao Ling, Ren-fang Zhou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890351

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


× No keyword cloud information.
  5 in total

1.  YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

Authors:  Zhong-Min Huang; Qi-Wen Huang; Ya-Qin Qin; Yan-Zhuan He; Hou-Ji Qin; Yiao-Nan Zhou; Xiang Xu; Mei-Jin Huang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

2.  Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population.

Authors:  Zhong-Min Huang; Qi-Wen Huang; Ya-Qin Qin; Chun-He Huang; Hou-Ji Qin; Yiao-Nan Zhou; Xiang Xu; Chun-Lei Lu
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

3.  Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B.

Authors:  You-Wen Tan; Yun Ye; Guo-Hong Ge; Wei Zhao; Jian-He Gan; Yun Zhao; Zhi-Lin Niu; Dong-Jun Zhang; Li Chen; Xue-Jun Yu; Li-Jun Yang
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 4.  The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis.

Authors:  Youwen Tan; Keqin Ding; Jing Su; Xuan Trinh; Zhihang Peng; Yuhua Gong; Li Chen; Qian Cui; Na Lei; Xin Chen; Rongbin Yu
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

5.  Hepatitis B virus genotyping among chronic hepatitis B individuals with resistance to Lamivudine in shahrekord, iran.

Authors:  Ali Karimi; Loghman Salimzadeh; Nader Bagheri
Journal:  Jundishapur J Microbiol       Date:  2014-04-01       Impact factor: 0.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.